| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 780 |
| 1 | PREDNISONE | 145 |
| 2 | RISANKIZUMAB-RZAA | 99 |
| 3 | OMEPRAZOLE MAGNESIUM | 79 |
| 4 | INFLIXIMAB | 76 |
| 5 | VEDOLIZUMAB | 76 |
| 6 | ERGOCALCIFEROL | 70 |
| 7 | OMEPRAZOLE | 70 |
| 8 | AZATHIOPRINE | 55 |
| 9 | CLOZAPINE | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | 1 | 0.0417 |
| 1 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 2 | 0.0123 |
| 2 | ONTRUZANT | 4 | 0.0077 |
| 3 | STREPTOMYCIN | 5 | 0.0044 |
| 4 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 3 | 0.0033 |
| 5 | CANDIDA ALBICANS | 2 | 0.0032 |
| 6 | CLORAZEPATE DIPOTASSIUM | 6 | 0.0031 |
| 7 | OMEPRAZOLE AND SODIUM BICARBONATE | 2 | 0.0030 |
| 8 | HALOPERIDOL DECANOATE | 5 | 0.0029 |
| 9 | I. V. FAT EMULSION | 2 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 239 |
| 1 | Interleukin-23 Antagonist [EPC] | 138 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 135 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 116 |
| 4 | Proton Pump Inhibitor [EPC] | 112 |
| 5 | Benzodiazepine [EPC] | 110 |
| 6 | Platinum-based Drug [EPC] | 93 |
| 7 | Atypical Antipsychotic [EPC] | 92 |
| 8 | Integrin Receptor Antagonist [EPC] | 85 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 85 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 28 | 0.0021 |
| 1 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0016 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0015 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 3 | 0.0014 |
| 4 | Phosphate Binder [EPC] | 3 | 0.0010 |
| 5 | Bile Acid Sequestrant [EPC] | 11 | 0.0009 |
| 6 | Reducing and Complexing Thiol [EPC] | 2 | 0.0008 |
| 7 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 8 | Standardized Insect Venom Allergenic Extract [EPC] | 5 | 0.0007 |
| 9 | Non-Standardized Insect Allergenic Extract [EPC] | 4 | 0.0007 |